LYEL
Lyell Immunopharma Inc
9.30$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -507.5% | – | – | – | – | – | |
| – | +241.9% | +217.3% | +20.9% | +23.0% | -3.1% | -41.2% | |
| – | +111.4% | +87.0% | +31.7% | -42.5% | -29.6% | +26.2% | |
| – | -30.2% | +152.6% | -22.5% | – | – | – | |
| – | -100.3% | – | -2,142.7% | – | -191.2% | – | |
| – | +220.8% | +27.2% | -62.9% | -88.9% | -82.7% | +68.1% | |
| – | -35.3% | -55.6% | -90.5% | – | -33.5% | -55.8% | |
| – | +6,281.6% | – | -100.1% | -0.9% | – | – | |
| – | +35.8% | -15.8% | -97.3% | -83.6% | -23.9% | +3,701.4% | |
| – | – | +261.8% | -211.0% | – | -274.9% | – | |
| – | -1,006.5% | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.